Predicting the risk of graves disease relapse: commentary on “thyroid peroxidase antibody positivity is associated with relapse-free survival following antithyroid drug treatment for graves disease”

Endocrine Practice,Volume 26, Issue 9, Page 1039-1041, September 2020.

Source: Endocrine Practice - September 29, 2020 Category: Endocrinology Authors: D. Gallo M. L. Tanda E. Piantanida Source Type: research